Globus Medical Inc

US

GMED

Health Care

51.25 ₽

Current price

Buy
51.25 ₽

Target price 00%

Ranks rating

76

  • Position in sub-industry

    164 / 663

  • Position in country

    3259 / 14179

  • Return on Assets, %

    5.2

    -11.9

  • Net income margin, %

    2.4

    -12.5

  • EBITDA margin, %

    15.8

    -2.5

  • Debt to Equity, %

    10.4

    15

  • Intangible assets and goodwill, %

    46.3

    3.9

  • Revenue CAGR 3Y, %

    25.7

    12.6

  • Total Equity change 1Y, %

    116.5

    0

  • Revenue Y, % chg

    53.3

    4.6

  • P/E

    44.3

    28.3

  • P/BV

    1.7

    1.7

  • P/S

    4.4

    3.7

  • EV/S

    4.3

    3.2

  • EV/EBITDA

    19.8

    -0.2

  • Average Analyst recommendation

    Hold

    Hold

  • Average upside forecasts, %

    16.1

    66.5

  • Forward P/E

    18

    19.2

  • Expected dividend per share

    0

    0

  • Payout Ratio, %

    0

    17.3

Get an analytical review of this company

Competitors

Ranks

  • Dexcom Inc

    00%

  • Boston Scientific Corp

    00%

  • Globus Medical Inc

    00%

  • Intuitive Surgical Inc

    00%

  • Stryker Corp

    00%

  • Edwards Lifesciences Corp

    00%

  • IDEXX Laboratories Inc

    00%

  • Abbott Laboratories

    00%

  • GE Healthcare Technologies Inc

    00%

  • Becton Dickinson and Co

    00%

Ready-made portfolio of the best Russian stocks

  • Created by artificial intelligence
  • Verified by analysts
  • Available even to beginners

Company information

  • Country

    United States of America

  • Sector

    Health Care

  • Industry group

    Health Care Equipment & Services

  • Industry

    Health Care Equipment & Supplies

  • Sub-sector

    Health Care

  • Capitalization (millions of $)

    6994.6

  • Ticker

    GMED.K

  • ISIN

    US3795772082

  • IPO date

    2012-03-08

  • Availability on Russian exchanges

    Yes

  • Reporting for

    2024-02-21

  • Date fact. publication of reports

    2023-12-31

Company Description

Globus Medical, Inc. is a medical device company. The Company is primarily focused on implants that promote healing in patients with musculoskeletal disorders. The Company group its products into two categories: Musculoskeletal Solutions and Enabling Technologies. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and surgical instruments used in an expansive range of spinal, orthopedic and neurosurgical procedures. Its Enabling Technologies are comprised of imaging, navigation and robotics (INR) solutions for assisted surgery, which are computer-assisted intelligent systems designed to improve a surgeon’s capabilities, and ultimately improve patient care and reduce radiation exposure for all involved. Its INR solutions include the ExcelsiusGPS platform, which is a robotic guidance and navigation system that supports minimally invasive and open procedures with screw and interbody spacer placement applications.